Efficacy and Safety of BMS-986263 in Adults with Compensated Cirrhosis from NASH
Phase 2
Recruiting
- Conditions
- Compensated cirrhosis from NASH
- Registration Number
- JPRN-jRCT2011200024
- Lead Sponsor
- Oliveira De Claudia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 270
Inclusion Criteria
Participants with liver biopsy fibrosis score stage 4 performed within 6 months
Exclusion Criteria
-Hepatic decompensation
-Known immunocompromised status or any disease or condition which might compromise participant safety
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in liver fibrosis as determined by liver biopsy
- Secondary Outcome Measures
Name Time Method Safety, tolerability, PK of BMS-986263